Evidence map›Paper›PMID 36915084›Full record

ArticleJournal of nanobiotechnology2023

Cu-doped TiO

Evelien Hesemans, Neshat Saffarzadeh, Christy Maksoudian, Mukaddes Izci, Tianjiao Chu, Carla Rios Luci, Yuqing Wang, Hendrik Naatz, Sebastian Thieme, Cornelia Richter and 4 more

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Eco-friendly Cu-TiOAMB Express · 2026
    Article
  4. Review
  5. Article
  6. PFKFB2-Driven Glycolysis Promotes Dendritic Cell Maturation and Exacerbates Acute Lung Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Review
  8. Article
  9. Recent advances in copper homeostasis-involved tumor theranostics.Asian journal of pharmaceutical sciences · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Evelien Hesemans *NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Neshat Saffarzadeh *NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Christy MaksoudianNanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Mukaddes IzciNanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Tianjiao ChuNanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Carla Rios LuciNanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Yuqing WangLeibniz Institute for Materials Engineering IWT, Badgasteiner Straße 3, 28359, Bremen, Germany.
Hendrik NaatzLeibniz Institute for Materials Engineering IWT, Badgasteiner Straße 3, 28359, Bremen, Germany.
Sebastian ThiemeUniversitatsKlinikum, Dresden, Germany.
Cornelia RichterUniversitatsKlinikum, Dresden, Germany.
Bella B ManshianTranslational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Suman PokhrelLeibniz Institute for Materials Engineering IWT, Badgasteiner Straße 3, 28359, Bremen, Germany.
Lutz MädlerLeibniz Institute for Materials Engineering IWT, Badgasteiner Straße 3, 28359, Bremen, Germany.
Stefaan J SoenenNanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. s.soenen@kuleuven.be.

Funding

China Scholarship Council CSCDeutsche Forschungsgemeinschaft MA3333/13-1European Research Council 757398Fonds Wetenschappelijk Onderzoek FWO-SBFonds Wetenschappelijk Onderzoek G0B2919NKU Leuven 3M210428
6 · The paper itself

Abstract

Nanoparticle-mediated cancer immunotherapy holds great promise, but more efforts are needed to obtain nanoformulations that result in a full scale activation of innate and adaptive immune components that specifically target the tumors. We generated a series of copper-doped TiO

Indexed as

Cancer VaccinesNanoparticlesNeoplasmsVaccinesAnimalsDendritic CellsHumansImmunotherapyMiceTitaniumCancer VaccinesTitaniumtitanium dioxideVaccinesDendritic cell vaccineMetal (oxide) nanoparticlesNanomedicineTumor therapy

Identifiers

PMID36915084
PMCPMC10009859

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read341
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.